A leading neuroscientist and Oxford University startup are working with Unilever and Beiersdorf to investigate whether there might be a skin biomarker for Alzheimer’s disease.
Addressing attendees at last month’s IFSCC Congress 2022 in London, UK, Baroness Professor Susan Greenfield, founder and CEO of Neuro-Bio, a privately-owned biotech startup out of Oxford University, said work had been ongoing with Unilever for some time and was just underway with Beiersdorf.
‘We’ve all known anecdotally that the skin and brain are connected’
Greenfield said this avenue of research had been taken because of the knowledge that the skin and brain were “indeed in a constant two-way conversation”.
Follow us on Linkedin!